Clinical Trials Directory

Trials / Completed

CompletedNCT02518152

Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis

Efficacy Of Platelet Rich Fibrin With 1% Alendronate For Treatment Of Intrabony Defects In Chronic Periodontitis: A Randomized Controlled Clinical Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Government Dental College and Research Institute, Bangalore · Academic / Other
Sex
All
Age
30 Years – 50 Years
Healthy volunteers
Accepted

Summary

The present study is designed to evaluate the combined efficacy of Platelet Rich Fibrin (PRF) and 1% Alendronate (ALN) with open flap debridement (OFD) in treatment of intrabony defects in chronic periodontitis patients.

Detailed description

Background: Platelet-rich fibrin (PRF) is a second-generation platelet concentrate, act as reservoirs of growth factors and cytokines which are the key factors for regeneration of the bone and maturation of the soft tissue. Alendronate (ALN), a potent member of bisphosphonate group is known to promote tissue regeneration by inhibiting osteoclastic bone resorption and promoting osteoblastogenesis. The present study was designed to evaluate the combined efficacy of PRF and 1% ALN with open flap debridement (OFD) in treatment of intrabony defects in chronic periodontitis patients. Methods: Ninety patients with single defects were categorized into three groups: OFD alone, OFD with PRF,OFD with PRF+1% ALN. Clinical parameters; site specific plaque index (PI), modified sulcus bleeding index (mSBI), probing depth (PD), clinical attachment level (CAL) and gingival marginal level (GML) were recorded at baseline before surgery and 9 months post-operatively. Percentage radiographic intra-bony defect depth reduction (IBD) was evaluated at baseline and 9 months.

Conditions

Interventions

TypeNameDescription
PROCEDUREOpen flap debridement (OFD)Oral prophylaxis followed by Open flap debridement (OFD)
PROCEDUREOFD with Platelet rich fibrin (PRF)Oral prophylaxis followed by Open flap debridement (OFD) with Platelet rich fibrin (PRF) placement into the bone defect
PROCEDUREOFD with Platelet rich fibrin (PRF)+1% AlendronateOral prophylaxis followed by Open flap debridement (OFD) with Platelet rich fibrin (PRF)+1% Alendronate placement into the bone defect

Timeline

Start date
2014-10-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2015-08-07
Last updated
2015-08-07

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT02518152. Inclusion in this directory is not an endorsement.